Literature DB >> 7628944

Comparison of daily versus continuous administration of somatotropin on growth rate, feed intake, and body composition in intact female rats.

M J Azain1, T J Roberts, R J Martin, T R Kasser.   

Abstract

The response to continuous delivery or daily bolus injection of porcine somatotropin (pST) was compared in mature, pituitary-intact female rats (225 g). Growth rate in control rats was approximately 1 g/d over the 14-d study. There was a dose-dependent (0, .4, 1.2, and 3.6 mg of pST/d; P < .001) increase in rate of gain with an interaction (P < .001) of dose and mode of delivery. The slope of the dose-response curve for growth rate was linear on a logarithmic scale for both modes of delivery but was greater for continuous delivery. At the low dose (.4 mg/d) pST stimulated gain (21.7 g/14 d above control, P < .05) when administered by daily injection but failed to stimulate gain (6.0 g/14 d above control, NS) when delivered continuously. At the high dose (3.6 mg/d), gain (above that in control rats) was 49.1 and 79.7 g/14 d for daily and continuous delivery; the two modes were different (P < .05) from each other. Feed intake and liver weights were also stimulated by pST in a dose-dependent manner. The increase in liver size was accompanied by a dose-dependent increase in liver DNA, indicative of an increase in cell number. Increased carcass gain was largely accounted for by increased carcass protein accretion. Rates of carcass lipid accretion were lower than those for protein accretion and were further decreased by pST, particularly by the high dose administered by continuous delivery, where a negative lipid accretion value was observed. Circulating IGF-I was increased by pST (P < .001) but was not affected by the mode of delivery. The results demonstrate that the increased gain observed in mature rats is largely due to lean tissue accretion and is accompanied by an increase in feed intake.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7628944     DOI: 10.2527/1995.7341019x

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  6 in total

1.  Feed intake and protein skeletal muscle in growing mice treated with growth hormone: time course effects.

Authors:  M E López-Oliva; A Agis-Torres; M T Unzaga; E Muñoz-Martínez
Journal:  J Physiol Biochem       Date:  2000-03       Impact factor: 4.158

2.  A TRbeta-selective agonist confers resistance to diet-induced obesity.

Authors:  Beatriz S Amorim; Cintia B Ueta; Beatriz C G Freitas; Renata J Nassif; Cecília Helena de Azevedo Gouveia; Marcelo A Christoffolete; Anselmo S Moriscot; Carmen Lucia Lancelloti; Flávia Llimona; Hermes Vieira Barbeiro; Heraldo Possolo de Souza; Sergio Catanozi; Marisa Passarelli; Marcelo S Aoki; Antonio C Bianco; Miriam O Ribeiro
Journal:  J Endocrinol       Date:  2009-08-27       Impact factor: 4.286

3.  Neural growth hormone implicated in body weight sex differences.

Authors:  Paul J Bonthuis; Emilie F Rissman
Journal:  Endocrinology       Date:  2013-07-16       Impact factor: 4.736

4.  Daily energy balance in growth hormone receptor/binding protein (GHR -/-) gene-disrupted mice is achieved through an increase in dark-phase energy efficiency.

Authors:  Kenneth A Longo; Darlene E Berryman; Bruce Kelder; Soratree Charoenthongtrakul; Peter S Distefano; Brad J Geddes; John J Kopchick
Journal:  Growth Horm IGF Res       Date:  2009-09-10       Impact factor: 2.372

5.  Comparison of pulsatile vs. continuous administration of human placental growth hormone in female C57BL/6J mice.

Authors:  Shutan Liao; Mark H Vickers; Angharad Evans; Joanna L Stanley; Philip N Baker; Jo K Perry
Journal:  Endocrine       Date:  2016-08-11       Impact factor: 3.633

6.  Ghrelin-induced Food Intake, but not GH Secretion, Requires the Expression of the GH Receptor in the Brain of Male Mice.

Authors:  Frederick Wasinski; Franco Barrile; João A B Pedroso; Paula G F Quaresma; Willian O Dos Santos; Edward O List; John J Kopchick; Mario Perelló; Jose Donato
Journal:  Endocrinology       Date:  2021-07-01       Impact factor: 4.736

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.